Skip to main content Accessibility help
×
Home

Perfusion Imaging of Tumefactive Demyelinating Lesions Compared to High Grade Gliomas

  • Natalie E. Parks (a1), Virender Bhan (a1) and Jai J. Shankar (a2)
  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Perfusion Imaging of Tumefactive Demyelinating Lesions Compared to High Grade Gliomas
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Perfusion Imaging of Tumefactive Demyelinating Lesions Compared to High Grade Gliomas
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Perfusion Imaging of Tumefactive Demyelinating Lesions Compared to High Grade Gliomas
      Available formats
      ×

Abstract

Copyright

Corresponding author

Correspondence to: Jai J. Shankar, Division of Neuroradiology, QEII Halifax Infirmary, 1796 Summer Street, Room 3305A, Halifax, Nova Scotia, Canada B3H 3A7. Email: shivajai1@gmail.com

References

Hide All
1. Lucchinetti, CF, Gavrilova, RH, Metz, I, et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008;131:1759-1775.
2. Xia, L, Lin, S, Wang, ZC, et al. Tumefactive demyelinating lesions: Nine cases and a review of the literature. Neurosurg Rev. 2009;32:171-179.
3. Jain, R, Ellika, S, Lehman, NL, et al. Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT? J Neurooncol. 2010;97:383-388.
4. Ernst, T, Chang, L, Walot, I, Huff, K. Physiologic MRI of a tumefactive multiple sclerosis lesion. Neurology. 1998;51:1486-1488.
5. Cha, S, Pierce, S, Knopp, EA, et al. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol. 2001;22:1109-1116.
6. Cha, S, Knopp, EA, Johnson, G, Wetzel, SG, Litt, AW, Zagzag, D. Intracranial mass lesions: Dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology. 2002;223:11-29.
7. Hakyemez, B, Erdogan, C, Yildiz, H, Bozdogan, E, Parlak, M. Tumefactive demyelinating lesion: Perfusion-weighted imaging findings. EJR Extra. 2005;53:95-98.
8. Law, M, Yang, S, Babb, JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol. 2004;25:746-755.
9. Law, M, Yang, S, Wang, H, et al. Glioma grading: Sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol. 2003;24:1989-1998.
10. Hourani, R, Brant, LJ, Rizk, T, Weingart, JD, Barker, PB, Horska, A. Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults? AJNR Am J Neuroradiol. 2008;29:366-372.
11. Ginsberg, LE, Fuller, GN, Hashmi, M, Leeds, NE, Schomer, DF. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: Histopathological evaluation of a series. Surg Neurol. 1998;49:436-440.
12. Mansour, A, Qandeel, M, Abdel-Razeq, H, Abu Ali, HA. MR imaging features of intracranial primary CNS lymphoma in immune competent patients. Cancer Imaging. 2014;14:22.
13. Masdeu, JC, Quinto, C, Olivera, C, Tenner, M, Leslie, D, Visintainer, P. Open-ring imaging sign: Highly specific for atypical brain demyelination. Neurology. 2000;54:1427-1433.
14. Mitha, AP, Scott, JN, George, D, Hanson, A, MacRae, ME, Bell, RB. Tumefactive demyelinating lesions. Can J Neurol Sci. 2007;34:362-364.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed